Frits van Rhee Selected Research

Frits van Rhee Research Topics

Disease

73	Multiple Myeloma 04/2024 - 01/2003
24	Neoplasms (Cancer) 10/2023 - 05/2005
22	Castleman Disease (Castleman's Disease) 02/2024 - 07/2010
12	Chromosome Aberrations (Chromosome Abnormalities) 01/2024 - 04/2006
10	Edema (Dropsy) 02/2024 - 04/2016
10	Thrombocytopenia (Thrombopenia) 02/2024 - 03/2017
9	Fever (Fevers) 02/2024 - 07/2013
7	Inflammation (Inflammations) 01/2022 - 01/2019
7	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2022 - 08/2010
7	Disease Progression 02/2021 - 03/2006
6	Multi-centric Castleman's Disease 08/2022 - 05/2014
5	Fibrosis (Cirrhosis) 02/2024 - 01/2018
5	Bone Diseases (Bone Disease) 10/2023 - 09/2009
5	Cytokine Release Syndrome 01/2022 - 05/2014
4	Lymphadenopathy 02/2024 - 04/2016
4	Anemia 02/2024 - 10/2015
3	Infections 03/2024 - 10/2015
3	Renal Insufficiency (Renal Failure) 11/2023 - 10/2021
3	Primary Myelofibrosis (Myelosclerosis) 01/2022 - 01/2019
3	Smoldering Multiple Myeloma 02/2021 - 10/2008
3	Fatigue 03/2020 - 07/2013
2	Neutropenia 07/2023 - 03/2020
2	Paraproteinemias (Monoclonal Gammopathy) 11/2022 - 09/2006
2	Hypoalbuminemia 01/2022 - 03/2017
2	Genetic Translocation (Chromosomal Translocation) 01/2022 - 07/2014
2	Thrombocytosis (Thrombocythemia) 01/2022 - 03/2017
2	Cytopenia 01/2019 - 03/2017
2	Hematologic Neoplasms (Hematological Malignancy) 11/2018 - 02/2016
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 06/2013 - 01/2008
2	Leukemia 06/2013 - 08/2012
2	Testicular Neoplasms (Testicular Cancer) 05/2011 - 11/2007
1	Hyperferritinemia 03/2024
1	Immunoglobulin G4-Related Disease 02/2024
1	Agammaglobulinemia (Hypogammaglobulinemia) 07/2023
1	Residual Neoplasm 01/2022
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022
1	COVID-19 01/2022
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2022
1	Communicable Diseases (Infectious Diseases) 10/2021
1	Ehrlichiosis 08/2021
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 08/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021
1	Nausea 03/2020

Drug/Important Bio-Agent (IBA)

16	Interleukin-6 (Interleukin 6)IBA 01/2022 - 08/2010
13	Monoclonal AntibodiesIBA 01/2022 - 09/2009
13	siltuximabIBA 01/2022 - 08/2010
12	Thalidomide (Thalomid)FDA Link 12/2023 - 07/2003
10	Bortezomib (Velcade)FDA Link 12/2023 - 07/2007
8	Reticulin (Reticular Fiber)IBA 02/2024 - 01/2018
7	Melphalan (Alkeran)FDA LinkGeneric 12/2023 - 03/2006
7	CytokinesIBA 01/2022 - 05/2014
7	C-Reactive ProteinIBA 01/2022 - 10/2006
5	Lenalidomide (CC 5013)FDA Link 04/2024 - 08/2012
5	Chimeric Antigen ReceptorsIBA 02/2024 - 01/2022
5	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 02/2024 - 01/2023
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2007
4	Dexamethasone (Maxidex)FDA LinkGeneric 04/2024 - 08/2010
4	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2024 - 10/2006
4	Biomarkers (Surrogate Marker)IBA 11/2022 - 02/2007
4	daratumumabIBA 08/2021 - 01/2018
4	elotuzumabIBA 06/2014 - 05/2008
4	AntigensIBA 05/2011 - 05/2005
3	Proteasome InhibitorsIBA 04/2024 - 02/2008
3	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2019
3	Messenger RNA (mRNA)IBA 04/2010 - 09/2006
2	ixazomibIBA 04/2024 - 07/2021
2	Intravenous Immunoglobulins (IVIG)FDA Link 03/2024 - 07/2023
2	Immunoglobulin G (IgG)IBA 02/2024 - 01/2022
2	Hemoglobins (Hemoglobin)IBA 02/2024 - 07/2013
2	Bispecific AntibodiesIBA 07/2023 - 01/2022
2	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 01/2018
2	Agammaglobulinaemia Tyrosine KinaseIBA 01/2022 - 06/2013
2	Phosphotransferases (Kinase)IBA 01/2020 - 11/2018
2	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2016 - 01/2016
2	InterleukinsIBA 10/2015 - 08/2014
2	VaccinesIBA 09/2010 - 11/2005
1	Transferrin (beta 2 Transferrin)IBA 03/2024
1	B-Cell Maturation AntigenIBA 01/2024
1	Cisplatin (Platino)FDA LinkGeneric 12/2023
1	Etoposide (VP 16)FDA LinkGeneric 12/2023
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2023
1	Cystatin MIBA 10/2023
1	NIMA-Related KinasesIBA 10/2023
1	ChromatinIBA 10/2022
1	tocilizumab (atlizumab)FDA Link 01/2022
1	SteroidsIBA 01/2022
1	tisagenlecleucelIBA 01/2022
1	Telomerase (Telomerase Reverse Transcriptase)IBA 12/2021
1	Cell-Free Nucleic AcidsIBA 02/2021

Therapy/Procedure

49	Therapeutics 02/2024 - 07/2003
9	Drug Therapy (Chemotherapy) 11/2023 - 07/2003
7	Stem Cell Transplantation 03/2022 - 09/2006
7	Immunotherapy 04/2017 - 05/2005
5	Transplantation 01/2022 - 04/2006
4	Autologous Transplantation 03/2010 - 08/2007
3	Hematopoietic Stem Cell Transplantation 12/2023 - 03/2006
2	Homologous Transplantation 05/2006 - 01/2003
1	Aftercare (After-Treatment) 01/2022
1	Maintenance Chemotherapy 08/2021